|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.75 GBX | 0.00% |
|
-2.27% | -8.51% |
| 12-01 | IXICO plc Announces Scientific Advisory Board Appointments, Effective December 1, 2025 | CI |
| 11-17 | Ixico wins GBP3.7 million deal to support Huntington's Disease trial | AN |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5d. change | Varia. Jan 1. | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IXICO PLC | Other Biotechnology & Medical Research | 0.00% | -2.27% | -8.51% | 0.00% | -89.86% | 13.27M |  |  |  |
Technical Rankings Surperformance
- Stock Market
- Equities
- IXI Stock
- Charts IXICO plc
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition